ZG19018

· Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZG19018, covering 2024-02-01 to 2024-02-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors. [Phase 1, Phase 2]